FindTrial
Sign In

The Treatment and Prognosis Study of Thyroid Cancer Based on Cancer Registration System

The Treatment and Prognosis Study of Thyroid Cancer Based on Cancer Registration System

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018760
Enrollment
Unknown
Registered
2018-10-08
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Cancer

Interventions

Group 2:radioactive iodine treatment
Group 1:Surgery

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with various pathological types of thyroid cancer over the age of 18 years

Exclusion criteria

Exclusion criteria: Mental disorders, inability to communicate normally;Combined with serious organ dysfunction;Patients with malignant tumors in addition to gynecological tumors

Design outcomes

Primary

MeasureTime frame
metastases;—

Countries

China

Contacts

Public ContactJia Hongying

The Second Hospital of Shandong University

jiahongying@sdu.edu.cn+86 17660089053

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026